PICOFLO POWDER FOR SOLUTION

Country: Kanada

Bahasa: Inggeris

Sumber: Health Canada

Beli sekarang

Download Ciri produk (SPC)
10-05-2013

Bahan aktif:

CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE

Boleh didapati daripada:

PHARMASCIENCE INC

Kod ATC:

A06AB58

INN (Nama Antarabangsa):

SODIUM PICOSULFATE, COMBINATIONS

Dos:

12G; 3.5G; 10MG

Borang farmaseutikal:

POWDER FOR SOLUTION

Komposisi:

CITRIC ACID 12G; MAGNESIUM OXIDE 3.5G; SODIUM PICOSULFATE 10MG

Laluan pentadbiran:

ORAL

Unit dalam pakej:

2X16.1G

Jenis preskripsi:

Ethical

Kawasan terapeutik:

CATHARTICS AND LAXATIVES

Ringkasan produk:

Active ingredient group (AIG) number: 0350181002; AHFS:

Status kebenaran:

APPROVED

Tarikh kebenaran:

2011-07-19

Ciri produk

                                PRESCRIBING INFORMATION
PICOFLO
TM
Magnesium Oxide, Citric Acid and Sodium Picosulfate
Powder for Oral Solution
3.5 g, 12 g and 10 mg per sachet
PURGATIVE
PHARMASCIENCE INC.
6111 Royalmount Ave., Suite 100
Montreal, Quebec
H4P 2T4
Date of Revision:
May 7, 2013
CONTROL NUMBER: 162683
PicoFLO
TM
is a trademark of PHARMASCIENCE Inc.
_ _
_PicoFLO_
_TM_
_ Prescribing Information _
_Page 2 of 16_
TABLE OF CONTENTS
HEALTH PROFESSIONAL
INFORMATION..........................................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................4
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................7
DRUG INTERACTIONS
....................................................................................................8
DOSAGE AND ADMINISTRATION
................................................................................9
OVERDOSAGE
................................................................................................................11
ACTION AND CLINICAL PHARMACOLOGY
............................................................12
STORAGE AND STABILITY
..........................................................................................12
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................12
CONSUMER INFORMATION
.................................................................................................13
_ _
_PicoFLO_
_TM_
_ Prescribing Information _
_Page 3 of 16_
PICOFLO
TM
Magnesium Oxide, Citric Acid and Sodium Picosulfate
Powder for Oral Solution
Purgative
HEALTH PROFESSIONAL INFORMATION
SUMM
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Ciri produk Ciri produk Perancis 07-05-2013